MedPath

Frailty, Hip Fractures and Inflammatory Biomarkers

Recruiting
Conditions
Frailty
Hip Fracture
Inflammatory Biomarkers
Registration Number
NCT06614478
Lead Sponsor
University of Thessaly
Brief Summary

We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Detailed Description

Frailty (F) is a prevalent syndrome among elderly patient with hip fractures (HF) and has been linked to poor prognosis. Inflammatory biomarkers have been used as prognostic indexes in patients with HF. We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • age >65 years, ASA PS I-III, non- institutionalized, able to communicate patients
Exclusion Criteria
  • Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frailty statuspreoperatively

Frailty will be categorized based on the validated Groningen Frailty Indicator (GFI) as non-frail (NF, score 0,1), pre-frail (PF, score 2, 3) and severe frail (SF, score \>4).

Inflammatory biomarkerspreoperatively

Upon admission and immediate before surgery upper limits of white blood cells (WBC) within normal range (WBC \>8 10\^3/μL), NLR (neutrophils/lymphocytes), PLR (platelets/lymphocytes), CRP (C-reactive protein) and CLR (CRP/lymphocytes), will be recorded.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Larissa University Hospital

🇬🇷

Larissa, Thessaly, Greece

UHL

🇬🇷

Larissa, Thessaly, Greece

© Copyright 2025. All Rights Reserved by MedPath